Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ImmunoCellular Therapeutics Ltd Company Profile (NYSE:IMUC)

Consensus Ratings for ImmunoCellular Therapeutics Ltd (NYSE:IMUC) (?)
Ratings Breakdown: 1 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $6.00 (751.06% upside)

Analysts' Ratings History for ImmunoCellular Therapeutics Ltd (NYSE:IMUC)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/12/2013MLV & Co DowngradeBuy -> Hold$1.25 -> $6.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/30/2012 forward)
Discuss ImmunoCellular Therapeutics Ltd